ATE58896T1 - Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen. - Google Patents

Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen.

Info

Publication number
ATE58896T1
ATE58896T1 AT85109655T AT85109655T ATE58896T1 AT E58896 T1 ATE58896 T1 AT E58896T1 AT 85109655 T AT85109655 T AT 85109655T AT 85109655 T AT85109655 T AT 85109655T AT E58896 T1 ATE58896 T1 AT E58896T1
Authority
AT
Austria
Prior art keywords
processes
acylamino
hydroxy
production
intermediate products
Prior art date
Application number
AT85109655T
Other languages
English (en)
Inventor
Richard H Mueller
Jakob-Matthias Drossard
Peter H Ermann
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of ATE58896T1 publication Critical patent/ATE58896T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Cephalosporin Compounds (AREA)
AT85109655T 1984-08-03 1985-08-01 Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen. ATE58896T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/637,260 US4581170A (en) 1984-08-03 1984-08-03 N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EP85109655A EP0170280B1 (de) 1984-08-03 1985-08-01 Neue Zwischenprodukte und Verfahren zur Herstellung von 3-Acylamino-1-hydroxy-2-azetidinonen

Publications (1)

Publication Number Publication Date
ATE58896T1 true ATE58896T1 (de) 1990-12-15

Family

ID=24555200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85109655T ATE58896T1 (de) 1984-08-03 1985-08-01 Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen.

Country Status (12)

Country Link
US (1) US4581170A (de)
EP (2) EP0371004A1 (de)
JP (2) JPH06732B2 (de)
AT (1) ATE58896T1 (de)
AU (2) AU589567B2 (de)
CA (1) CA1268780C (de)
DE (1) DE3580803D1 (de)
DK (1) DK353385A (de)
FI (1) FI852974A7 (de)
IE (2) IE58758B1 (de)
NZ (1) NZ212750A (de)
ZA (1) ZA855492B (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670553A (en) * 1982-01-04 1987-06-02 E. R. Squibb & Sons, Inc. 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
EP0233607B1 (de) * 1986-02-18 1991-03-13 E.R. Squibb & Sons, Inc. [(2,2,2-Trichloroethoxy)methoxy]amin
US5037974A (en) * 1988-05-23 1991-08-06 Merck & Co., Inc. Cyclization process for synthesis of a beta-lactam carbapenem intermediate
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US20020147184A1 (en) * 2001-01-26 2002-10-10 Schering Corporation Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
SI1413331T1 (sl) * 2001-01-26 2008-02-29 Schering Corp Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
CA2434488A1 (en) * 2001-01-26 2002-08-01 Harry R. Davis Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
DK1385548T3 (da) * 2001-01-26 2007-09-10 Schering Corp Kombinationer af sterolabsorptionsinhibitor(er) med (et eller flere) kardiovaskulære midler til behandling af vaskulære tilstande
JP4711600B2 (ja) * 2001-01-26 2011-06-29 シェーリング コーポレイション シトステロール血症の処置のための置換アゼチジノン化合物の使用
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
EP1785144A3 (de) * 2001-01-26 2007-05-23 Shering Corporation Kombinationen von Gallensäurebinder(n) und Sterolabsorptionshemmer(n) und entsprechende Behandlung für vaskuläre Indikationen
WO2002096415A2 (en) * 2001-05-25 2002-12-05 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7132415B2 (en) * 2001-09-21 2006-11-07 Schering Corporation Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
ATE411018T1 (de) * 2001-09-21 2008-10-15 Schering Corp Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
CA2504878A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
CN1756755A (zh) * 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja) * 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
CN100439361C (zh) 2003-03-07 2008-12-03 先灵公司 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
EP1680189A2 (de) * 2003-11-05 2006-07-19 Schering Corporation Kombinationen von lipidmodulierenden mitteln mit substituierten azetidinonen zur behandlung von vaskularen erkrankungen
US9436903B2 (en) 2013-03-04 2016-09-06 Hello Inc. Wearable device with magnets with a defined distance between adjacent magnets
US9526422B2 (en) 2013-03-04 2016-12-27 Hello Inc. System for monitoring individuals with a monitoring device, telemetry system, activity manager and a feedback system
US9634921B2 (en) 2013-03-04 2017-04-25 Hello Inc. Wearable device coupled by magnets positioned in a frame in an interior of the wearable device with at least one electronic circuit
US9357922B2 (en) 2013-03-04 2016-06-07 Hello Inc. User or patient monitoring systems with one or more analysis tools
US9427160B2 (en) 2013-03-04 2016-08-30 Hello Inc. Wearable device with overlapping ends coupled by magnets positioned in the wearable device by an undercut
US9432091B2 (en) 2013-03-04 2016-08-30 Hello Inc. Telemetry system with wireless power receiver and monitoring devices
US9298882B2 (en) 2013-03-04 2016-03-29 Hello Inc. Methods using patient monitoring devices with unique patient IDs and a telemetry system
US9159223B2 (en) 2013-03-04 2015-10-13 Hello, Inc. User monitoring device configured to be in communication with an emergency response system or team
US9424508B2 (en) 2013-03-04 2016-08-23 Hello Inc. Wearable device with magnets having first and second polarities
US9398854B2 (en) 2013-03-04 2016-07-26 Hello Inc. System with a monitoring device that monitors individual activities, behaviors or habit information and communicates with a database with corresponding individual base information for comparison
US9427053B2 (en) 2013-03-04 2016-08-30 Hello Inc. Wearable device with magnets magnetized through their widths or thickness
US9204798B2 (en) 2013-03-04 2015-12-08 Hello, Inc. System for monitoring health, wellness and fitness with feedback
US9704209B2 (en) 2013-03-04 2017-07-11 Hello Inc. Monitoring system and device with sensors and user profiles based on biometric user information
US9345403B2 (en) 2013-03-04 2016-05-24 Hello Inc. Wireless monitoring system with activity manager for monitoring user activity
US9149189B2 (en) 2013-03-04 2015-10-06 Hello, Inc. User or patient monitoring methods using one or more analysis tools
US9662015B2 (en) 2013-03-04 2017-05-30 Hello Inc. System or device with wearable devices having one or more sensors with assignment of a wearable device user identifier to a wearable device user
US9420856B2 (en) 2013-03-04 2016-08-23 Hello Inc. Wearable device with adjacent magnets magnetized in different directions
US9532716B2 (en) 2013-03-04 2017-01-03 Hello Inc. Systems using lifestyle database analysis to provide feedback
US9737214B2 (en) 2013-03-04 2017-08-22 Hello Inc. Wireless monitoring of patient exercise and lifestyle
US9320434B2 (en) 2013-03-04 2016-04-26 Hello Inc. Patient monitoring systems and messages that send alerts to patients only when the patient is awake
US9367793B2 (en) 2013-03-04 2016-06-14 Hello Inc. Wearable device with magnets distanced from exterior surfaces of the wearable device
US9582748B2 (en) 2013-03-04 2017-02-28 Hello Inc. Base charging station for monitoring device
US9430938B2 (en) 2013-03-04 2016-08-30 Hello Inc. Monitoring device with selectable wireless communication
US9330561B2 (en) 2013-03-04 2016-05-03 Hello Inc. Remote communication systems and methods for communicating with a building gateway control to control building systems and elements
US9445651B2 (en) 2013-03-04 2016-09-20 Hello Inc. Wearable device with overlapping ends coupled by magnets
US9420857B2 (en) 2013-03-04 2016-08-23 Hello Inc. Wearable device with interior frame
US9339188B2 (en) 2013-03-04 2016-05-17 James Proud Methods from monitoring health, wellness and fitness with feedback
US9361572B2 (en) 2013-03-04 2016-06-07 Hello Inc. Wearable device with magnets positioned at opposing ends and overlapped from one side to another
US9406220B2 (en) 2013-03-04 2016-08-02 Hello Inc. Telemetry system with tracking receiver devices
US9848776B2 (en) 2013-03-04 2017-12-26 Hello Inc. Methods using activity manager for monitoring user activity
US9427189B2 (en) 2013-03-04 2016-08-30 Hello Inc. Monitoring system and device with sensors that are responsive to skin pigmentation
US9530089B2 (en) 2013-03-04 2016-12-27 Hello Inc. Wearable device with overlapping ends coupled by magnets of a selected width, length and depth
US9392939B2 (en) 2013-03-04 2016-07-19 Hello Inc. Methods using a monitoring device to monitor individual activities, behaviors or habit information and communicate with a database with corresponding individual base information for comparison
US9553486B2 (en) 2013-03-04 2017-01-24 Hello Inc. Monitoring system and device with sensors that is remotely powered
US8810430B2 (en) 2013-03-04 2014-08-19 Hello Inc. System using wearable device with unique user ID and telemetry system
US9345404B2 (en) 2013-03-04 2016-05-24 Hello Inc. Mobile device that monitors an individuals activities, behaviors, habits or health parameters
US9610030B2 (en) 2015-01-23 2017-04-04 Hello Inc. Room monitoring device and sleep analysis methods
US20160220198A1 (en) 2013-06-21 2016-08-04 Hello Inc. Mobile device that monitors an individuals activities, behaviors, habits or health parameters
US10009581B2 (en) 2015-01-02 2018-06-26 Fitbit, Inc. Room monitoring device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442240A1 (fr) * 1978-11-27 1980-06-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique comportant un groupement eliminable sur le radical amino, leur procede de preparation et leur application a la synthese de produits actifs comme medicaments
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
NZ205642A (en) * 1982-10-06 1986-08-08 Squibb & Sons Inc Beta-lactams and pharmaceutical compositions

Also Published As

Publication number Publication date
IE58758B1 (en) 1993-11-03
FI852974L (fi) 1986-02-04
JPS6147445A (ja) 1986-03-07
CA1262357A (en) 1989-10-17
NZ212750A (en) 1989-04-26
EP0170280A1 (de) 1986-02-05
EP0170280B1 (de) 1990-12-05
US4581170A (en) 1986-04-08
AU614663B2 (en) 1991-09-05
AU4083589A (en) 1990-02-08
JPH069528A (ja) 1994-01-18
CA1268780C (fr) 1990-05-08
IE851917L (en) 1986-02-03
FI852974A7 (fi) 1986-02-04
FI852974A0 (fi) 1985-08-01
ZA855492B (en) 1986-03-26
AU589567B2 (en) 1989-10-19
EP0371004A1 (de) 1990-05-30
IE58771B1 (en) 1993-11-03
AU4535685A (en) 1986-02-06
DE3580803D1 (de) 1991-01-17
JPH0662532B2 (ja) 1994-08-17
JPH06732B2 (ja) 1994-01-05
DK353385D0 (da) 1985-08-02
DK353385A (da) 1986-02-04

Similar Documents

Publication Publication Date Title
ATE58896T1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen.
NO874350D0 (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
HU908495D0 (en) Process for the production of a-nor-steroid-3-carbonic acid derivatives
DE69322708D1 (de) Neues Verfahren zur Herstellung von 7-(substituierten)-9-[(substistuierter Glycyl)amido]-6-demethyl-6-deoxytetracyclinen
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
ATE64154T1 (de) Verfahren zur herstellung von l-carnitin auf mikrobiologischem weg.
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
ATE51617T1 (de) Verfahren zur herstellung von 4-phenyl-pyrrolderivaten.
ATE71104T1 (de) Neues verfahren zur herstellung von sphingosinderivaten.
BR8806558A (pt) Processos para preparacao de compostos
ATE88476T1 (de) Verfahren zur herstellung von 7-aca-derivaten.
ATE43342T1 (de) Verfahren zur herstellung von hydrogeno- oder halogenosilanen.
ATE2144T1 (de) Verfahren zur herstellung von carbazolen und zwischenprodukte dafuer.
DE69008382D1 (de) Verfahren zur Herstellung von Organosiliziumverbindungen.
DE69024999D1 (de) Verfahren zur Herstellung von 2-Oxindol-1-carboxamiden
DE69332707D1 (de) Verfahren zur Herstellung von 3-Vinylcephalosporinen
DK231586D0 (da) Oxadiazolylimidazobenzodiazepinforbindelse, farmaceutisk praeparat indeholdende samme, fremgangsmaade til fremstilling af forbindelsen og fremgangsmaade til behandling af en centralnervesystemsygdom
ATE4310T1 (de) Verfahren zur herstellung von o-xylol und ethylbenzol.
ATE23340T1 (de) 3-alkylthio-2-0-carbamoylpropan-1,2-diol-1-0phosphocholine und verfahren zu ihrer herstellung.
ATE71102T1 (de) Azaphospholene und ihre verwendung.
ATE66459T1 (de) Herstellungsverfahren von trifluormethylverbindungen.
ATE77373T1 (de) Verfahren zur herstellung von chinolinsaeurederivaten.
ATE56852T1 (de) Zusammensetzung und verfahren zur herstellung von mineralsalzen.
ATE56704T1 (de) Verfahren zur herstellung von 2-oxindole-1carboxamiden und deren zwischenprodukte.
ATE53020T1 (de) Verfahren zur herstellung von cis-bicyclo(3.3.0)- octylidenderivaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee